Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Julphar
Merck
Baxter
Johnson and Johnson
Queensland Health
Colorcon
McKesson

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,847,170

« Back to Dashboard

Which drugs does patent 5,847,170 protect, and when does it expire?

Patent 5,847,170 protects JEVTANA KIT and is included in one NDA.

Protection for JEVTANA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has one hundred and eighteen patent family members in forty-five countries.
Summary for Patent: 5,847,170
Title: Taxoids, their preparation and pharmaceutical compositions containing them
Abstract:New taxoids of general formula (I): ##STR1## their preparation and pharmaceutical compositions containing them, and the new products of general formula (I) in which Z represents a radical of general formula (II): ##STR2## display noteworthy antitumour and antileukaemic properties.
Inventor(s): Bouchard; Herve (Ivry-sur-Seine, FR), Bourzat; Jean-Dominique (Vincennes, FR), Commer.cedilla.on; Alain (Vitry-sur-Seine, FR)
Assignee: Rhone-Poulenc Rorer, S.A. (Antony Cedex, FR)
Application Number:08/622,011
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,847,170
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Process;

Drugs Protected by US Patent 5,847,170

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sanofi Aventis Us JEVTANA KIT cabazitaxel SOLUTION;IV (INFUSION) 201023-001 Jun 17, 2010 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,847,170

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France95 03545Mar 27, 1995
France95 15381Dec 22, 1995

Non-Orange Book US Patents Family Members for Patent 5,847,170

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,372,780 Methods of treating cell lines expressing multidrug resistance P-glycoprotein ➤ Try a Free Trial
6,187,916 Process for the preparation of taxane derivatives and .beta.-lactam intermediates therefor ➤ Try a Free Trial
5,889,043 Taxoids, preparation thereof and pharmaceutical Compositions containing same ➤ Try a Free Trial
6,331,635 Taxoids, their preparation and pharmaceutical compositions containing them ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,847,170

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 753 ➤ Try a Free Trial
African Regional IP Organization (ARIPO) 785 ➤ Try a Free Trial
African Regional IP Organization (ARIPO) 9701090 ➤ Try a Free Trial
African Regional IP Organization (ARIPO) 9701093 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
Healthtrust
Moodys
Fuji
Julphar
Harvard Business School
UBS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.